US 11,938,195 B2
Upconversion nanoparticle peptide conjugates
Ka-Leung Wong, Hong Kong (CN); Hong Lok Lung, Hong Kong (CN); Shuai Zha, Hong Kong (CN); and Ho-Fai Chau, Hong Kong (CN)
Assigned to BP InnoMed Limited, Hong Kong (CN)
Filed by BP InnoMed Limited, Hong Kong (CN)
Filed on Jun. 11, 2021, as Appl. No. 17/303,981.
Prior Publication US 2022/0401578 A1, Dec. 22, 2022
Int. Cl. A61K 47/69 (2017.01); A61K 51/12 (2006.01)
CPC A61K 47/6935 (2017.08) [A61K 47/6923 (2017.08); A61K 51/1244 (2013.01)] 23 Claims
 
1. A polypeptide comprising three peptide sequences or a pharmaceutically acceptable salt or zwitterion thereof; wherein the three peptide sequences are SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID N: 3 and the polypeptide comprises in order from N-terminus to C-terminus: SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 1 or SEQ ID NO: 3, SEQ ID NO: 2, and SEQ SEQ ID NO: 1.